MDimune Press Releases

• Published on October 5, 2023 - 00:04 GMT

  MDimune Inc. broadens its global footprint with residency at JLABS @ Shanghai

  SEONGDONG-GU, SEOUL, SOUTH KOREA, October 5, 2023 /⁨EINPresswire.com⁩/ -- MDimune Inc. announced today that it took up residence at Johnson & Johnson Innovation – JLABS @ Shanghai (‘JLABS’), located in Shanghai, China, starting in September. A …

  Distribution channels: Business & Economy, Companies ...
• Published on February 22, 2023 - 08:24 GMT

  

  MDimune Named as a Finalist in the Prestigious 2023 Edison Awards™

  SEONGDONG-GU, SEOUL, SOUTH KOREA, February 22, 2023 /⁨EINPresswire.com⁩/ -- MDimune Inc., a Korean biotech company developing BioDroneTM platform technology, has been named a finalist in the 2023 Edison Awards. The company is being honored in the Health, …

  Distribution channels: Business & Economy, Companies ...
• Published on January 26, 2023 - 00:07 GMT

  MDimune announces a collaboration with Hanyang University on the projects selected through the 3rd BioDrone™ Award

  SEONGDONG-GU, SEOUL, SOUTH KOREA, January 26, 2023 /⁨EINPresswire.com⁩/ -- MDimune Inc., a Korean biotech company developing BioDrone™ platform technology based on cell-derived vesicles (CDVs), announces funding of two research projects focusing on next- …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on January 5, 2023 - 07:50 GMT

  MDimune announced the development of the GMP manufacturing process for cell-derived vesicles in the latest publication

  SEONGDONG-GU, SEOUL, SOUTH KOREA, January 5, 2023 /⁨EINPresswire.com⁩/ -- MDimune Inc., a Korean biotech company developing BioDrone™ platform technology based on cell-derived vesicles (CDVs), announced the publication of data in the Journal of …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on December 7, 2022 - 04:52 GMT

  

  MDimune Inc. enters into a Research Collaboration Agreement with ANU to develop therapeutics for AMD

  SEONGDONG-GU, SEOUL, SOUTH KOREA, December 7, 2022 /⁨EINPresswire.com⁩/ -- MDimune Inc., a Korean biotech company developing BioDroneTM platform technology based on cell-derived vesicles (CDVs), announced a research collaboration agreement with the Clear …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on November 7, 2022 - 03:44 GMT

  

  MDimune partners with Ewha Womans University Medical Center to develop inflammatory bowel diseases therapeutics

  SEONGDONG-GU, SEOUL, SOUTH KOREA, November 7, 2022 /⁨EINPresswire.com⁩/ -- MDimune, Inc., a Korean biotech company developing BioDrone™ platform technology based on cell-derived vesicles (CDVs), announced a business agreement with Ewha Womans University …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on October 24, 2022 - 02:14 GMT

  

  MDimune and SensoryCure announce a collaboration to develop therapeutics for hearing loss

  SEONGDONG-GU, SEOUL, SOUTH KOREA, October 24, 2022 /⁨EINPresswire.com⁩/ -- MDimune, Inc., a Korean biotech company developing BioDroneTM platform technology based on cell-derived vesicles (CDVs), enters into an MOU with SensoryCure to collaborate on the …

  Distribution channels: Business & Economy, Companies ...
• Published on February 28, 2022 - 07:14 GMT

  

  MDimune Signs Research Agreement with YiPSCELL to Develop iPSC-based BioDrone® Therapeutics

  SEONGDONG-GU, SEOUL, SOUTH KOREA, February 28, 2022 /⁨EINPresswire.com⁩/ -- MDimune has announced the joint research agreement with YiPSCELL to develop BioDrone® Platform therapeutics based on induced pluripotent stem cells (iPSCs). YiPSCELL is a South …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on December 27, 2021 - 04:42 GMT

  MDimune’s 2021 BioDrone® Award Nominations: Research Grant Awarded to NUS Pharmacy Research Team

  SEONGDONG-GU, SEOUL, SOUTH KOREA, December 27, 2021 /⁨EINPresswire.com⁩/ -- MDimune Inc., a biotech company developing BioDrone® platform technology based on cell-derived vesicles (CDVs), has announced the finalists of the research-funded project; the 2021 …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on October 29, 2021 - 08:04 GMT

  

  MDimune, pens FAF1 mRNA cancer drug deal with Kainos Medicine

  SEONGDONG-GU, SEOUL, SOUTH KOREA, October 29, 2021 /⁨EINPresswire.com⁩/ -- MDimune Inc. and Kainos Medicine, Inc., has inked a collaboration pact and possible licensing deal with MDimune Inc. for disruptive cancer therapy development based on cell-derived …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on October 22, 2021 - 06:55 GMT

  NeoCura and MDimune settle CDVs-mediated mRNA collaboration

  SEONGDONG-GU, SEOUL, SOUTH KOREA, October 22, 2021 /⁨EINPresswire.com⁩/ -- NeoCura Bio-Medical Technology Co., Ltd, (“NeoCura”), a leading AI-enabled RNA precision medicine company based on research, development and MDimune Inc. (“MDimune”), a leading …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on September 13, 2021 - 03:13 GMT

  

  Successful demonstration of BioDrone® platform-based drug delivery to the Prokr1-deficient C2C12 myoblasts

  SEONGDONG-GU, SEOUL, SOUTH KOREA, September 13, 2021 /⁨EINPresswire.com⁩/ -- MDimune Inc., a leading cell-derived vesicles (CDVs) company in South Korea has announced the outcomes of the research collaboration with Prof. Joonghoon Park’s team at Seoul …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on September 9, 2021 - 06:34 GMT

  

  Mdimune Inc. Announces Research Collaboration with the Seoul National University for Gene Editing based on CDVs

  The outcomes of this research may revolutionize a breakthrough of the current limitations in gene editing nuclease delivery techniques. SEONGDONG-GU, SEOUL, SOUTH KOREA, September 9, 2021 /⁨EINPresswire.com⁩/ -- MDimune Inc., a leading Extracellular …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on September 6, 2021 - 06:36 GMT

  

  Vect-Horus and MDimune Collaborate to Develop a Novel Approach to CNS Drug Delivery Based on Cell-derived Vesicles

  SEONGDONG-GU, SEOUL, SOUTH KOREA, September 6, 2021 /⁨EINPresswire.com⁩/ -- MDimune Inc. and Vect-Horus are please to announce today the signing of a Research Collaboration Agreement. MDimune is a South Korean biotech company dedicated to the development …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on May 13, 2021 - 06:42 GMT

  

  Reyon and MDimune Sign CDVs-Mediated mRNA Delivery Partnership

  SEONGDONG-GU, SEOUL, SOUTH KOREA, May 13, 2021 /⁨EINPresswire.com⁩/ -- Reyon Pharmaceuticals Co. Ltd. (“Reyon”), a bio & chemical pharmaceutical company based on research, production, and sales capabilities and MDimune Inc. (“MDimune”), a leading …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on May 11, 2021 - 04:17 GMT

  

  Navigo Proteins and MDimune Enter into a Research Collaboration on Affilin®-Mediated Targeting of Extracellular Vesicles

  Solid tumor-specific scaffold protein ligands from Navigo combined with MDimune’s BioDrone® Platform for novel targeted extracellular vesicle-mediated delivery SEONGDONG-GU, SEOUL, SOUTH KOREA, May 11, 2021 /⁨EINPresswire.com⁩/ -- Halle/Saale, Germany and …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on April 5, 2021 - 06:41 GMT

  

  MDimune and Evercyte form partnership for developing tumor-targeting EVs

  SEONGDONG-GU, SEOUL, SOUTH KOREA, April 5, 2021 /⁨EINPresswire.com⁩/ -- MDimune Inc. and Evercyte GmbH announced a strategic collaboration to develop tumor-targeted drug delivery by combining MDimune’s BioDrone® platform technology based on cell-derived …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on March 15, 2021 - 08:52 GMT

  

  ExonanoRNA and MDimune Enter Service Agreement to Advance Targeted Drug Delivery for Cancer

  SEONGDONG-GU, SEOUL, SOUTH KOREA, March 15, 2021 /⁨EINPresswire.com⁩/ -- ExonanoRNA LLC., based in Columbus, Ohio, and MDimune Inc., headquartered in Seoul, South Korea, have entered into a service agreement to develop targeted siRNA therapy in oncology …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on November 3, 2020 - 01:02 GMT

  

  Four Korean Researchers Receive MDimune’s 1st BioDrone® Award

  SEONGDONG-GU, SEOUL, SOUTH KOREA, November 3, 2020 /⁨EINPresswire.com⁩/ -- MDimune Inc., a Korean biotech company developing BioDrone® platform technology, announced the signing of research agreements with Pohang University of Science and Technology ( …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on October 28, 2020 - 07:24 GMT

  

  MDimune Selected by Lonza to the Startup Creasphere Program

  SEONGDONG-GU, SEOUL, SOUTH KOREA, October 28, 2020 /⁨EINPresswire.com⁩/ -- Plug and Play, headquartered in Silicon Valley, California, announced that MDimune Inc., a Korean biotech company developing BioDrone® platform technology, has been selected to the …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...